PMID- 19016146
OWN - NLM
STAT- MEDLINE
DCOM- 20090203
LR  - 20101118
IS  - 1525-6049 (Electronic)
IS  - 0886-022X (Linking)
VI  - 30
IP  - 10
DP  - 2008
TI  - Clinical outcome following the use of inadequate solutions for continuous 
      veno-venous hemodiofiltration.
PG  - 959-64
LID - 10.1080/08860220802422028 [doi]
AB  - BACKGROUND: A short time ago, commercially available diafiltration and 
      replacement fluids could be found o n the hospital in Turkey. Instead, peritoneal 
      dialysis solution (PDS) for continue veno-venous hemodiafiltration (CVVHDF) 
      therapy and normal saline as replacement fluid are used. In this retrospective 
      study, we investigated the effects of PDS and bicarbonate-buffered hemofiltration 
      solution (Bic-HFS). METHODS: We did a retrospective chart review of 24 patients 
      treated with continue renal replacement therapy (CRRT) between January 2004 and 
      February 2008. Peritoneal dialysis solution (PDS) was used in 14 patients, and 
      bicarbonate-buffered hemodialysis solution (bic-HFS) was used in 10 patients. 
      RESULTS: Demographic data, laboratory findings, and mortality rate were similar 
      both groups. Blood glucose and lactate levels were higher in the PD group than 
      the bic-HFS group (p < 0.05). Hyperglycemia occurred more frequent in the PDS 
      group than in the bic-HFS group (64% versus 30%, respectively; p < 0.05). 
      Metabolic acidosis occurred in eight patients (57%) in the PDS group and three 
      patients (30%) in the bic-HFS group (p < 0.05). Hypotension was higher in the PDS 
      group (10, 71%) than in the bic-HFS group (3, 30%; p < 0.05). CONCLUSION: Using 
      PDS fluid as dialysate for CVVHDF therapy is not a preferable solution because of 
      the metabolic disturbances that it can cause.
FAU - Celik, Jale Bengi
AU  - Celik JB
AD  - Meram Medicine Faculty, Department of Anaesthesiology, Selcuk University, Konya, 
      Turkey. jalecelik@hotmail.com
FAU - Topal, Ahmet
AU  - Topal A
FAU - Kartal, Elmas
AU  - Kartal E
FAU - Yosunkaya, Alper
AU  - Yosunkaya A
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - England
TA  - Ren Fail
JT  - Renal failure
JID - 8701128
RN  - 0 (Dialysis Solutions)
SB  - IM
MH  - Acidosis/*etiology
MH  - Acute Kidney Injury/complications/*therapy
MH  - Aged
MH  - Dialysis Solutions/*adverse effects/standards
MH  - Female
MH  - *Hemodiafiltration
MH  - Humans
MH  - Hyperglycemia/etiology
MH  - Male
MH  - Middle Aged
MH  - Retrospective Studies
MH  - Treatment Outcome
EDAT- 2008/11/19 09:00
MHDA- 2009/02/04 09:00
CRDT- 2008/11/19 09:00
PHST- 2008/11/19 09:00 [pubmed]
PHST- 2009/02/04 09:00 [medline]
PHST- 2008/11/19 09:00 [entrez]
AID - 905629592 [pii]
AID - 10.1080/08860220802422028 [doi]
PST - ppublish
SO  - Ren Fail. 2008;30(10):959-64. doi: 10.1080/08860220802422028.